Dow Up1.63% Nasdaq Up0.97%

Infinity Pharmaceuticals, Inc. (INFI)

-NasdaqGS
12.78 0.46(3.47%) Oct 17, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development28,165  34,491  26,592  26,857  
Selling General and Administrative7,057  6,804  6,492  7,319  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (35,222) (41,295) (33,084) (34,176)
Income from Continuing Operations
Total Other Income/Expenses Net136  168  159  238  
Earnings Before Interest And Taxes(35,086)(41,127)(32,925)(33,938)
Interest Expense2,938  1,139   -   -  
Income Before Tax(38,024)(42,266)(32,925)(33,938)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(38,024)(42,266)(32,925)(33,938)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (38,024) (42,266) (32,925) (33,938)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (38,024) (42,266) (32,925) (33,938)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.